Board of directors of Harbin Pharmaceutical Co., Ltd. decides to appoint Xu Haiying as general manager

On March 4, Harbin Pharmaceutical Co., Ltd issued the announcement on the resolution of the 16th board of directors of the 8th session of Harbin Pharmaceutical Group Co., Ltd., saying that after the deliberation of the board of directors of the company, it was decided to appoint Ms Xu Haiying as the general manager of the company Upon the nomination of general manager Ms Xu Haiying, the board of directors of the company decided to appoint Mr Liu Bangmin and Mr Xiao Qiang as the deputy general manager of the company Ms Xu Haiying, born in 1967, holds a bachelor's degree in economics and a master's degree in international finance from Peking University He used to be president of Novartis group in China, general manager of China investment innovation investment management company, operation director of China Merchants Group health industry business department, and general manager of China Merchants Group Health Industry Investment Company Mr Liu Bangmin, born in 1971, holds a bachelor's degree from Zhejiang Medical University and a master's degree from CEIBS He used to be the director of immune rheumatism Business Department of Abbott China and the president of Longsheng Pharmaceutical Group in China Mr Xiao Qiang, born in 1970, has a bachelor's degree in economics from Renmin University of China, a master's degree in Business Administration from Kellogg Business School of Northwestern University, and a doctor's degree in economics from Florida International University He used to be director of management consulting business of PWC pharmaceutical industry and general manager of Strategic Development Department of China Merchants Group Health business department The full text of the announcement is as follows: